 Administration, Topical
"Administration, Topical" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example.
| Descriptor ID |
D000287
|
| MeSH Number(s) |
E02.319.267.120
|
| Concept/Terms |
Administration, Topical- Administration, Topical
- Drug Administration, Topical
- Topical Drug Administration
- Topical Administration
- Administrations, Topical
- Topical Administrations
- Administration, Topical Drug
- Administrations, Topical Drug
- Drug Administrations, Topical
- Topical Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Topical".
Below are MeSH descriptors whose meaning is more specific than "Administration, Topical".
This graph shows the total number of publications written about "Administration, Topical" by people in this website by year, and whether "Administration, Topical" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 1997 | 0 | 4 | 4 | | 1998 | 0 | 3 | 3 | | 1999 | 0 | 2 | 2 | | 2000 | 0 | 1 | 1 | | 2001 | 0 | 1 | 1 | | 2002 | 0 | 2 | 2 | | 2003 | 0 | 5 | 5 | | 2004 | 0 | 6 | 6 | | 2005 | 0 | 5 | 5 | | 2006 | 0 | 2 | 2 | | 2007 | 1 | 7 | 8 | | 2008 | 0 | 4 | 4 | | 2009 | 0 | 2 | 2 | | 2010 | 0 | 3 | 3 | | 2011 | 0 | 4 | 4 | | 2012 | 0 | 3 | 3 | | 2013 | 0 | 4 | 4 | | 2014 | 0 | 2 | 2 | | 2015 | 0 | 9 | 9 | | 2016 | 0 | 5 | 5 | | 2017 | 0 | 4 | 4 | | 2018 | 0 | 5 | 5 | | 2019 | 0 | 3 | 3 | | 2020 | 0 | 7 | 7 | | 2021 | 0 | 3 | 3 | | 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Administration, Topical" by people in Profiles.
-
Gushiken LFS, Beserra FP, Hussni MF, Gonzaga MT, Ribeiro VP, de Souza PF, Campos JCL, Massaro TNC, Hussni CA, Takahira RK, Marcato PD, Bastos JK, Pellizzon CH. Beta-caryophyllene as an antioxidant, anti-inflammatory and re-epithelialization activities in a rat skin wound excision model. Oxid Med Cell Longev. 2022; 2022:9004014.
-
Bardill JR, Laughter MR, Stager M, Liechty KW, Krebs MD, Zgheib C. Topical gel-based biomaterials for the treatment of diabetic foot ulcers. Acta Biomater. 2022 01 15; 138:73-91.
-
Maghfour J, Rietcheck H, Szeto MD, Rundle CW, Sivesind TE, Dellavalle RP, Lio P, Dunnick CA, Fernandez J, Yardley H. Tolerability profile of topical cannabidiol and palmitoylethanolamide: a compilation of single-centre randomized evaluator-blinded clinical and in?vitro studies in normal skin. Clin Exp Dermatol. 2021 Dec; 46(8):1518-1529.
-
Szeto MD, Maghfour J, Sivesind TE, Anderson J, Olayinka JT, Mamo A, Runion TM, Dellavalle RP. Interferon and Toll-Like Receptor 7 Response in COVID-19: Implications of Topical Imiquimod for Prophylaxis and Treatment. Dermatology. 2021; 237(6):847-856.
-
Binder EF, Christensen JC, Stevens-Lapsley J, Bartley J, Berry SD, Dobs AS, Fortinsky RH, Hildreth KL, Kiel DP, Kuchel GA, Marcus RL, McDonough CM, Orwig D, Sinacore DR, Schwartz RS, Volpi E, Magaziner J, Schechtman KB. A multi-center trial of exercise and testosterone therapy in women after hip fracture: Design, methods and impact of the COVID-19 pandemic. Contemp Clin Trials. 2021 05; 104:106356.
-
Maghfour J, Rundle CW, Rietcheck HR, Dercon S, Lio P, Mamo A, Runion TM, Fernandez J, Kahn J, Dellavalle RP, Yardley H. Assessing the effects of topical cannabidiol in patients with atopic dermatitis. Dermatol Online J. 2021 Feb 15; 27(2).
-
Scheman A, Chamlin S, Gurnee E, Roszko K. Targeted Balsam of Peru Diet for Pediatric Genital Contact Allergy. Dermatitis. 2020 Sep-Oct; 31(5):e53.
-
Vooturi S, Bourne D, Panda JJ, Choi S, Kim H, Yandrapu SK, Kompella UB. Effect of Particle Size and Viscosity of Suspensions on Topical Ocular Bioavailability of Budesonide, a Corticosteroid. J Ocul Pharmacol Ther. 2020 Jul/Aug; 36(6):404-409.
-
Paller AS, Siegfried EC, Tha?i D, Wollenberg A, Cork MJ, Arkwright PD, Gooderham M, Beck LA, Boguniewicz M, Sher L, Weisman J, O'Malley JT, Patel N, Hardin M, Graham NMH, Ruddy M, Sun X, Davis JD, Kamal MA, Khokhar FA, Weinreich DM, Yancopoulos GD, Beazley B, Bansal A, Shumel B. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11?years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial. J Am Acad Dermatol. 2020 Nov; 83(5):1282-1293.
-
Hirano I, Chan ES, Rank MA, Sharaf RN, Stollman NH, Stukus DR, Wang K, Greenhawt M, Falck-Ytter YT. AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2020 05; 124(5):416-423.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|